Julie E Chang

Summary

Affiliation: University of Wisconsin
Country: USA

Publications

  1. ncbi Therapeutic advances in the treatment of brain metastases
    Julie E Chang
    Hematology and Oncology Fellow, University of Wisconsin Hospital and Clinics, Madison, WI 53792, USA
    Clin Adv Hematol Oncol 5:54-64. 2007
  2. ncbi Radiotherapy and radiosensitizers in the treatment of glioblastoma multiforme
    Julie E Chang
    Department of Medicine, Section of Hematology and Oncology, University of Wisconsin School of Medicine and Public Health, Madison, WI 53792, USA
    Clin Adv Hematol Oncol 5:894-902, 907-15. 2007
  3. ncbi Current status of targeted therapies for mantle cell lymphoma
    Julie E Chang
    Department of Medicine, University of Wisconsin School of Medicine and Public Health, Madison, WI 53705, USA
    Drugs 71:2307-26. 2011

Detail Information

Publications3

  1. ncbi Therapeutic advances in the treatment of brain metastases
    Julie E Chang
    Hematology and Oncology Fellow, University of Wisconsin Hospital and Clinics, Madison, WI 53792, USA
    Clin Adv Hematol Oncol 5:54-64. 2007
    ..Systemic agents showing activity in brain metastases including temozolomide, RSR13, motexafin gadolinium, and lapatinib are being explored...
  2. ncbi Radiotherapy and radiosensitizers in the treatment of glioblastoma multiforme
    Julie E Chang
    Department of Medicine, Section of Hematology and Oncology, University of Wisconsin School of Medicine and Public Health, Madison, WI 53792, USA
    Clin Adv Hematol Oncol 5:894-902, 907-15. 2007
    ....
  3. ncbi Current status of targeted therapies for mantle cell lymphoma
    Julie E Chang
    Department of Medicine, University of Wisconsin School of Medicine and Public Health, Madison, WI 53705, USA
    Drugs 71:2307-26. 2011
    ..Although many of the agents appear to have modest single-agent activity, the favourable toxicity profile of many agents will make them best suited for incorporation into combination regimens...